CV Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2024

The following table outlines the total consideration transferred (in thousands):


Cash	$	192
Common shares		250
Earn-out		88
Total consideration transferred	$	530

The following table summarizes the assets acquired and liabilities assumed as of the acquisition date (in thousands):


Cash	$	18
Accounts receivable and other receivables		11
Inventories		133
Intangible assets		78
Other current assets		17
Fixed assets		38
Goodwill		334
Total assets		629

Accounts payable and accrued liabilities		27
Current notes payable		50
Deferred tax liabilities		22
Total liabilities		99
Net assets acquired	$	530

The following table outlines the total consideration transferred (in thousands):


Cash	$	37
Common shares		700
Earn-out		100
Total consideration transferred	$	837

The following table summarizes the assets acquired and liabilities assumed as of the acquisition date (in thousands):


Cash	$	31
Inventories		49
Intangible assets		38
Other non-current assets		11
Fixed assets		316
Goodwill		465
Total assets		910

Accounts payable and accrued liabilities		73
Total liabilities		73
Net assets acquired	$	837